세계의 오소바이오로직스 시장 점유율, 규모, 동향, 업계 분석 : 최종 용도별, 제품별, 용도별, 지역별, 부문 예측(2022-2030년)

The global orthobiologics market size is expected to reach USD 11.77 billion by 2030, according to a new study by Polaris Market Research. The report "Orthobiologics Market Share, Size, Trends, Industry Analysis Report, By Product (Demineralized Bone Matrix(DBM), Allograft, Bone Morphogenetic Protein (BMP), Viscosupplementation, Synthetic Bone Substitutes, Stem Cell Therapy, and Others); By Application; By End-Use; By Region; Segment Forecast, 2022 - 2030" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Increased use of platelet-rich plasma, homologous conditioned plasma, and adipose-generated stromal cell treatment is also predicted to contribute to market expansion. Orthobiologics, which are most usually connected with sports injuries, are organic substances, including platelet-rich plasma (PRP) or stem cells, that are used to accelerate the recovery process for musculoskeletal problems.

They can be used alone as well as in conjunction with traditional pharmacological and non-pharmaceutical therapy options. Orthobiologic therapies, in particular, consider introducing large concentrations of natural sources of cellular ingredients to an injury site to accelerate the recovery process of muscles, ligaments, soft tissue, joints, and other organs, thereby reducing recovery time and due to injuries pain, and swelling.

Further, the development in the occurrence of sports injuries and road accidents is likely to drive the growth of the market during the forecast period. As per the John Hopkins Medicines, in the United States, about 30 million children and teenagers participate in some type of sports, and every year, around 3.5 million injuries occur, which results in some loss of engagement time.

Thus, orthobiologic therapies are utilized in sports medicine to treat either acute or chronic disorders, including typical overuse injuries. Athletes and orthopedists frequently turn to orthobiologic therapy to quickly recover an athlete to the pre-injury physical state. Most orthopedists will try to employ biologics instead of medications and/or intrusive surgery.

Furthermore, the rise in the prevalence of spinal illnesses and disorders is expected to fuel the expansion of the market. For instance, as per the National Spinal Cord Injury Statistical Center, the average annual incidence of SCI is around 54 instances per one million individuals, or approximately 17,810 additional SCI cases each year.

As per the WHO, every year, approximately 250 000 and 500 000 people worldwide develop a spinal cord injury (SCI). Most spinal cord accidents are caused by avoidable causes such as car accidents and falls. Therefore, the rising prevalence of sports injuries along with spinal disorders are the factors that are boosting the demand for orthobiologics therapy or treatment and are driving the market growth.

Orthobiologics Market Report Highlights

The soft tissue injuries segment is anticipated to grow at the fastest CAGR over the forecast period owing to a rise in sports-related injuries and the desire for orthobiologics for cartilage regeneration.

Spinal fusion segment accounted for a significant share of the global revenue due to the rising use of artificial matrices and allografts in spine fusion surgeries.

Asia Pacific is expected to witness substantial growth over the projected period. This is growing owing to increased healthcare spending, rising disposable personal wealth, and an increase in road traffic accidents in various nations. The public funding for health education and services is also rising.

The global players include Alphatec Spine Incorporation, DePuy Synthes, Incorporation, Exactech, Inc., Globus Medical, Inc., Globus Medical, Inc., Harvest Technologies Corporation, Orthofix Holdings, Inc., Stryker Corporation, SeaSpine Holdings Corporation, Wright Medical Group N.V., and Zimmer Biomet, Inc.

Polaris Market Research has segmented the Orthobiologics market report based on product, application, end-use, and region:

Orthobiologics, Product Outlook (Revenue - USD Billion, 2018 - 2030)

Demineralized Bone Matrix(DBM)

Allograft

Bone Morphogenetic Protein (BMP)

Viscosupplementation

Synthetic Bone Substitutes

Stem Cell Therapy

Others

Orthobiologics, Application Outlook (Revenue - USD Billion, 2018 - 2030)

Spinal Fusion

Trauma Repair

Osteoarthritis and Degenerative Arthritis

Soft Tissue Injuries

Maxillofacial and Dental Applications

Reconstructive Surgery

Orthobiologics, End-Use Outlook (Revenue - USD Billion, 2018 - 2030)

Hospitals

Orthopedic Clinics

Ambulatory Care Centers

Research and Academic Institutes

Others

Orthobiologics, Regional Outlook (Revenue - USD Billion, 2018 - 2030)

North America

U.S

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Global Orthobiologics Market Insights

• 4.1. Orthobiologics - Industry Snapshot
• 4.2. Orthobiologics Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Growth in aging population
    • 4.2.1.2. Increase in sports injuries
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. High cost of orthobiologics product
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTEL Analysis
• 4.5. Orthobiologics Market Industry Trends
• 4.6. Value Chain Analysis
• 4.7. COVID-19 Impact Analysis

5. Global Orthobiologics Market, by Product

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
• 5.3. Demineralized Bone Matrix(DBM)
  • 5.3.1. Global Orthobiologics Market, by Demineralized Bone Matrix(DBM), by Region, 2018 - 2030 (USD Billion)
• 5.4. Allograft
  • 5.4.1. Global Orthobiologics Market, by Allograft, by Region, 2018 - 2030 (USD Billion)
• 5.5. Bone Morphogenetic Protein (BMP)
  • 5.5.1. Global Orthobiologics Market, by Bone Morphogenetic Protein (BMP), by Region, 2018 - 2030 (USD Billion)
• 5.6. Viscosupplementation
  • 5.6.1. Global Orthobiologics Market, by Viscosupplementation, by Region, 2018 - 2030 (USD Billion)
• 5.7. Synthetic Bone Substitutes
  • 5.7.1. Global Orthobiologics Market, by Synthetic Bone Substitutes, by Region, 2018 - 2030 (USD Billion)
• 5.8. Stem Cell Therapy
  • 5.8.1. Global Orthobiologics Market, by Stem Cell Therapy, by Region, 2018 - 2030 (USD Billion)
• 5.9. Others
  • 5.9.1. Global Other Orthobiologics Market, by Region, 2018 - 2030 (USD Billion)

6. Global Orthobiologics Market, by Application

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
• 6.3. Spinal Fusion
  • 6.3.1. Global Orthobiologics Market, by Spinal Fusion, by Region, 2018 - 2030 (USD Billion)
• 6.4. Trauma Repair
  • 6.4.1. Global Orthobiologics Market, by Trauma Repair, by Region, 2018 - 2030 (USD Billion)
• 6.5. Osteoarthritis and Degenerative Arthritis
  • 6.5.1. Global Orthobiologics Market, by Osteoarthritis and Degenerative Arthritis, by Region, 2018 - 2030 (USD Billion)
• 6.6. Soft Tissue Injuries
  • 6.6.1. Global Orthobiologics Market, by Soft Tissue Injuries, by Region, 2018 - 2030 (USD Billion)
• 6.7. Maxillofacial and Dental Applications
  • 6.7.1. Global Orthobiologics Market, by Maxillofacial and Dental Applications, by Region, 2018 - 2030 (USD Billion)
• 6.8. Reconstructive Surgery
  • 6.8.1. Global Orthobiologics Market, by Reconstructive Surgery, by Region, 2018 - 2030 (USD Billion)

7. Global Orthobiologics Market, by End-Use

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Global Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
• 7.3. Hospitals
  • 7.3.1. Global Orthobiologics Market, by Hospitals, by Region, 2018 - 2030 (USD Billion)
• 7.4. Orthopedic Clinics
  • 7.4.1. Global Orthobiologics Market, by Orthopedic Clinics, by Region, 2018 - 2030 (USD Billion)
• 7.5. Ambulatory Care Centers
  • 7.5.1. Global Orthobiologics Market, by Ambulatory Care Centers, by Region, 2018 - 2030 (USD Billion)
• 7.6. Research and Academic Institutes
  • 7.6.1. Global Orthobiologics Market, by Research and Academic Institutes, by Region, 2018 - 2030 (USD Billion)
• 7.7. Others
  • 7.7.1. Global Other Orthobiologics Market, by Region, 2018 - 2030 (USD Billion)

8. Global Orthobiologics Market, by Geography

• 8.1. Key findings
• 8.2. Introduction
  • 8.2.1. Orthobiologics Market Assessment, By Geography, 2018 - 2030 (USD Billion)
• 8.3. Orthobiologics Market - North America
  • 8.3.1. North America: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
  • 8.3.2. North America: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
  • 8.3.3. North America: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • 8.3.4. Orthobiologics Market - U.S.
    • 8.3.4.1. U.S.: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
    • 8.3.4.2. U.S.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.3.4.3. U.S.: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • 8.3.5. Orthobiologics Market - Canada
    • 8.3.5.1. Canada: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
    • 8.3.5.2. Canada.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.3.5.3. Canada: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
• 8.4. Orthobiologics Market - Europe
  • 8.4.1. Europe: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
  • 8.4.2. Europe.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
  • 8.4.3. Europe: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • 8.4.4. Orthobiologics Market - UK
    • 8.4.4.1. UK: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
    • 8.4.4.2. UK.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.4.4.3. UK: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • 8.4.5. Orthobiologics Market - France
    • 8.4.5.1. France: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
    • 8.4.5.2. France.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.4.5.3. France: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • 8.4.6. Orthobiologics Market - Germany
    • 8.4.6.1. Germany: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
    • 8.4.6.2. Germany.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.4.6.3. Germany: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • 8.4.7. Orthobiologics Market - Italy
    • 8.4.7.1. Italy: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
    • 8.4.7.2. Italy.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.4.7.3. Italy: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • 8.4.8. Orthobiologics Market - Spain
    • 8.4.8.1. Spain: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
    • 8.4.8.2. Spain.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.4.8.3. Spain: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • 8.4.9. Orthobiologics Market - Netherlands
    • 8.4.9.1. Netherlands: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
    • 8.4.9.2. Netherlands.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.4.9.3. Netherlands: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • 8.4.10. Orthobiologics Market - Russia
    • 8.4.10.1. Russia: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
    • 8.4.10.2. Russia.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.4.10.3. Russia: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
• 8.5. Orthobiologics Market - Asia Pacific
  • 8.5.1. Asia Pacific: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
  • 8.5.2. Asia Pacific.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
  • 8.5.3. Asia Pacific: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • 8.5.4. Orthobiologics Market - China
    • 8.5.4.1. China: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
    • 8.5.4.2. China.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.5.4.3. China: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • 8.5.5. Orthobiologics Market - India
    • 8.5.5.1. India: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
    • 8.5.5.2. India.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.5.5.3. India: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • 8.5.6. Orthobiologics Market - Malaysia
    • 8.5.6.1. Malaysia: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
    • 8.5.6.2. Malaysia.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.5.6.3. Malaysia: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • 8.5.7. Orthobiologics Market - Japan
    • 8.5.7.1. Japan: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
    • 8.5.7.2. Japan.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.5.7.3. Japan: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • 8.5.8. Orthobiologics Market - Indonesia
    • 8.5.8.1. Indonesia: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
    • 8.5.8.2. Indonesia.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.5.8.3. Indonesia: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • 8.5.9. Orthobiologics Market - South Korea
    • 8.5.9.1. South Korea: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
    • 8.5.9.2. South Korea.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.5.9.3. South Korea: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
• 8.6. Orthobiologics Market - Middle East & Africa
  • 8.6.1. Middle East & Africa: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
  • 8.6.2. Middle East & Africa.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
  • 8.6.3. Middle East & Africa: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • 8.6.4. Orthobiologics Market - Saudi Arabia
    • 8.6.4.1. Saudi Arabia: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
    • 8.6.4.2. Saudi Arabia.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.6.4.3. Saudi Arabia: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • 8.6.5. Orthobiologics Market - UAE
    • 8.6.5.1. UAE: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
    • 8.6.5.2. UAE.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.6.5.3. UAE: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • 8.6.6. Orthobiologics Market - Israel
    • 8.6.6.1. Israel: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
    • 8.6.6.2. Israel.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.6.6.3. Israel: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • 8.6.7. Orthobiologics Market - South Africa
    • 8.6.7.1. South Africa: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
    • 8.6.7.2. South Africa.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.6.7.3. South Africa: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
• 8.7. Orthobiologics Market - Latin America
  • 8.7.1. Latin America: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
  • 8.7.2. Latin America.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
  • 8.7.3. Latin America: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • 8.7.4. Orthobiologics Market - Mexico
    • 8.7.4.1. Mexico: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
    • 8.7.4.2. Mexico.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.7.4.3. Mexico: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • 8.7.5. Orthobiologics Market - Brazil
    • 8.7.5.1. Brazil: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
    • 8.7.5.2. Brazil.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.7.5.3. Brazil: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • 8.7.6. Orthobiologics Market - Argentina
    • 8.7.6.1. Argentina: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
    • 8.7.6.2. Argentina.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.7.6.3. Argentina: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)

9. Competitive Landscape

• 9.1. Expansion and Acquisition Analysis
  • 9.1.1. Expansion
  • 9.1.2. Acquisitions
• 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

• 10.1. Alphatec Spine Incorporation
  • 10.1.1. Company Overview
  • 10.1.2. Financial Performance
  • 10.1.3. Product Benchmarking
  • 10.1.4. Recent Development
• 10.2. Arthrex Inc.
  • 10.2.1. Company Overview
  • 10.2.2. Financial Performance
  • 10.2.3. Product Benchmarking
  • 10.2.4. Recent Development
• 10.3. Bone Biologics Corporation
  • 10.3.1. Company Overview
  • 10.3.2. Financial Performance
  • 10.3.3. Product Benchmarking
  • 10.3.4. Recent Development
• 10.4. Bacterin International Corporation
  • 10.4.1. Company Overview
  • 10.4.2. Financial Performance
  • 10.4.3. Product Benchmarking
  • 10.4.4. Recent Development
• 10.5. DePuy Synthes, Incorporation
  • 10.5.1. Company Overview
  • 10.5.2. Financial Performance
  • 10.5.3. Product Benchmarking
  • 10.5.4. Recent Development
• 10.6. Exactech, Inc
  • 10.6.1. Company Overview
  • 10.6.2. Financial Performance
  • 10.6.3. Product Benchmarking
  • 10.6.4. Recent Development
• 10.7. Genzyme Corporation
  • 10.7.1. Company Overview
  • 10.7.2. Financial Performance
  • 10.7.3. Product Benchmarking
  • 10.7.4. Recent Development
• 10.8. Globus Medical, Inc
  • 10.8.1. Company Overview
  • 10.8.2. Financial Performance
  • 10.8.3. Product Benchmarking
  • 10.8.4. Recent Development
• 10.9. Globus Medical, Inc
  • 10.9.1. Company Overview
  • 10.9.2. Financial Performance
  • 10.9.3. Product Benchmarking
  • 10.9.4. Recent Development
• 10.10. Harvest Technologies Corporation
  • 10.10.1. Company Overview
  • 10.10.2. Financial Performance
  • 10.10.3. Product Benchmarking
  • 10.10.4. Recent Development
• 10.11. Integra Lifesciences Corporation
  • 10.11.1. Company Overview
  • 10.11.2. Financial Performance
  • 10.11.3. Product Benchmarking
  • 10.11.4. Recent Development
• 10.12. Medtronic, Plc
  • 10.12.1. Company Overview
  • 10.12.2. Financial Performance
  • 10.12.3. Product Benchmarking
  • 10.12.4. Recent Development
• 10.13. NuVasive, Incorporation
  • 10.13.1. Company Overview
  • 10.13.2. Financial Performance
  • 10.13.3. Product Benchmarking
  • 10.13.4. Recent Development
• 10.14. Orthofix Holdings, Inc
  • 10.14.1. Company Overview
  • 10.14.2. Financial Performance
  • 10.14.3. Product Benchmarking
  • 10.14.4. Recent Development
• 10.15. Ortho Regenerative Technologies Inc
  • 10.15.1. Company Overview
  • 10.15.2. Financial Performance
  • 10.15.3. Product Benchmarking
  • 10.15.4. Recent Development
• 10.16. Stryker Corporation
  • 10.16.1. Company Overview
  • 10.16.2. Financial Performance
  • 10.16.3. Product Benchmarking
  • 10.16.4. Recent Development
• 10.17. SeaSpine Holdings Corporation
  • 10.17.1. Company Overview
  • 10.17.2. Financial Performance
  • 10.17.3. Product Benchmarking
  • 10.17.4. Recent Development
• 10.18. Wright Medical Group N.V
  • 10.18.1. Company Overview
  • 10.18.2. Financial Performance
  • 10.18.3. Product Benchmarking
  • 10.18.4. Recent Development
• 10.19. Zimmer Biomet, Inc
  • 10.19.1. Company Overview
  • 10.19.2. Financial Performance
  • 10.19.3. Product Benchmarking
  • 10.19.4. Recent Development